CIK 0001411690 · Non-accelerated filer<br>Smaller reporting company
Bionano Genomics, Inc.
Sign in to watch- Ticker
- BNGO
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 261756290
- Phone
- (858) 888-7600
- Business address
- 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- BioNano Genomics, Inc, Bionano Genomics, Inc, BioNanomatrix Inc
- Open-market buys, last 90 days
- $9,705
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,705. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-17 | Linney Yvonne Director | Grant or award · Stock Option (right to buy) | +40,751 | 40,751 | ||
| 2021-06-15 | Shippy Richard Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2021-06-10 | BARKER DAVID L Director | Grant or award · Stock Option (right to buy) | +7,528 | 7,528 | ||
| 2021-06-10 | TWOMEY CHRISTOPHER J Director | Grant or award · Stock Option (right to buy) | +7,528 | 7,528 | ||
| 2021-06-10 | Mamuszka Hannah Director | Grant or award · Stock Option (right to buy) | +7,528 | 7,528 | ||
| 2021-06-10 | Luderer Albert Director | Grant or award · Stock Option (right to buy) | +7,528 | 7,528 | ||
| 2021-06-10 | Linney Yvonne Director | Grant or award · Stock Option (right to buy) | +7,528 | 7,528 | ||
| 2021-06-10 | Vuori Kristiina MD Director | Grant or award · Stock Option (right to buy) | +7,528 | 7,528 | ||
| 2021-06-01 | Priar Robert J Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2021-05-26 | Stewart Christopher P. Chief Financial Officer | Option exercise | +25,000 | $0.56 | $14K | 33,000 |
| 2021-05-26 | Stewart Christopher P. Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −25,000 | 200,000 | ||
| 2021-05-12 | Holmlin R. Erik President and CEO | Grant or award | +290,000 | 295,191 | ||
| 2021-05-12 | Holmlin R. Erik President and CEO | Grant or award | +290,000 | 585,191 | ||
| 2021-05-12 | OLDAKOWSKI MARK Chief Operating Officer | Grant or award | +240,000 | 252,086 | ||
| 2021-04-01 | Chaubey Alka Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2021-04-01 | Stewart Christopher P. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2021-04-01 | Holmlin R. Erik President and CEO | Grant or award · Stock Option (Right to Buy) | +775,000 | 775,000 | ||
| 2021-04-01 | OLDAKOWSKI MARK Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2021-01-22 | Stewart Christopher P. Chief Financial Officer | Grant or award | +8,000 | $6.00 | $48K | 8,000 |
| 2020-09-01 | Chaubey Alka Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 |
Page 8 of 14 · 266 trades